Publications by authors named "H Rosing"

Claim this Profile
A
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.
Pauline L M Buitelaar, Hilde Rosing, Jos H Beijnen, Neeltje Steeghs, Alwin D R Huitema

Biomed Chromatogr· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasib.
Marinda Meertens, L Daniëlle de Jong, Niels de Vries, Hilde Rosing, Jos H Beijnen

J Pharm Biomed Anal· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.
Ma Ida Mohmaed Ali, Lisa T van der Heijden, Matthijs Tibben, Hilde Rosing, Raween Kalicharan

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validated LC-MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI-0690 in Preclinical Target Site PK/PD Studies.
Wietse M Schouten, Katrien van Bocxlaer, Hilde Rosing, Alwin D R Huitema, Jos H Beijnen

Biomed Chromatogr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.
Jonathan E Knikman, Mirjam de With, Niels Heersche, Marta Lopez-Yurda, Arnold Baars, Hilde Rosing

Eur J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis